These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37277843)
21. Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents. Vesikari T; Østergaard L; Beeslaar J; Absalon J; Eiden JJ; Jansen KU; Jones TR; Harris SL; Maansson R; Munson S; O'Neill RE; York LJ; Perez JL Vaccine; 2019 Mar; 37(12):1710-1719. PubMed ID: 30770221 [TBL] [Abstract][Full Text] [Related]
22. Acute post-infectious cerebellar ataxia due to co-infection of human herpesvirus-6 and adenovirus mimicking myositis. Naselli A; Pala G; Cresta F; Finetti M; Biancheri R; Renna S Ital J Pediatr; 2014 Nov; 40():98. PubMed ID: 25425177 [TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. Gossger N; Snape MD; Yu LM; Finn A; Bona G; Esposito S; Principi N; Diez-Domingo J; Sokal E; Becker B; Kieninger D; Prymula R; Dull P; Ypma E; Toneatto D; Kimura A; Pollard AJ; JAMA; 2012 Feb; 307(6):573-82. PubMed ID: 22318278 [TBL] [Abstract][Full Text] [Related]
24. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children. Hansen J; Zhang L; Eaton A; Baxter R; Robertson CA; Decker MD; Greenberg DP; Bassily E; Klein NP Vaccine; 2018 Apr; 36(16):2133-2138. PubMed ID: 29550195 [TBL] [Abstract][Full Text] [Related]
25. Acute cerebellar ataxia after influenza vaccination with recurrence and marked cerebellar atrophy. Saito H; Yanagisawa T Tohoku J Exp Med; 1989 May; 158(1):95-103. PubMed ID: 2781544 [TBL] [Abstract][Full Text] [Related]
26. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States. Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872 [TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. Marshall HS; Vesikari T; Richmond PC; Wysocki J; Szenborn L; Beeslaar J; Maguire JD; Balmer P; O'Neill R; Anderson AS; Prégaldien JL; Maansson R; Jiang HQ; Perez JL Lancet Infect Dis; 2023 Jan; 23(1):103-116. PubMed ID: 36087588 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial. Davis K; Valente Pinto M; Andrews NJ; Goldblatt D; Borrow R; Findlow H; Southern J; Partington J; Plested E; Patel S; Holland A; Matheson M; England A; Hallis B; Miller E; Snape MD Lancet Infect Dis; 2021 May; 21(5):688-696. PubMed ID: 33428870 [TBL] [Abstract][Full Text] [Related]
29. Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal. De Serres G; Billard MN; Gariépy MC; Roy MC; Boucher FD; Gagné H; Belley S; Toth E; Landry M; Skowronski DM Vaccine; 2019 Aug; 37(35):4996-5002. PubMed ID: 31307873 [TBL] [Abstract][Full Text] [Related]
30. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody. Shiihara T; Kato M; Konno A; Takahashi Y; Hayasaka K Brain Dev; 2007 May; 29(4):254-6. PubMed ID: 17049194 [TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus-1 as a rare etiology of isolated acute cerebellitis: case report and literature review. Paketci C; Edem P; Okumus C; Sarioglu FC; Bayram E; Hiz S; Yis U J Neurovirol; 2020 Apr; 26(2):270-272. PubMed ID: 31515702 [TBL] [Abstract][Full Text] [Related]
32. [The acute cerebellar ataxia, reccurrence of disease after 5 years--a case report]. Sobolewski P Przegl Epidemiol; 2006; 60 Suppl 1():148-50. PubMed ID: 16909793 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence. Pouwels KB; Hak E; van der Ende A; Christensen H; van den Dobbelsteen GP; Postma MJ Hum Vaccin Immunother; 2013 May; 9(5):1129-38. PubMed ID: 23406816 [TBL] [Abstract][Full Text] [Related]
34. Acute Ataxia in Childhood: 11-Year Experience at a Major Pediatric Neurology Referral Center. Thakkar K; Maricich SM; Alper G J Child Neurol; 2016 Aug; 31(9):1156-60. PubMed ID: 27071467 [TBL] [Abstract][Full Text] [Related]
35. From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Perez JL; Absalon J; Beeslaar J; Balmer P; Jansen KU; Jones TR; Harris S; York LJ; Jiang Q; Radley D; Anderson AS; Crowther G; Eiden JJ Expert Rev Vaccines; 2018 Jun; 17(6):461-477. PubMed ID: 29883226 [TBL] [Abstract][Full Text] [Related]
36. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial. P Safadi MA; Martinon-Torres F; Weckx LY; Moreira ED; da Fonseca Lima EJ; Mensi I; Calabresi M; Toneatto D Vaccine; 2017 Apr; 35(16):2052-2059. PubMed ID: 28318767 [TBL] [Abstract][Full Text] [Related]
38. Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease. Scholz S; Schwarz M; Beck E; Meszaros K; Schneider M; Ultsch B; Greiner W Infect Dis Ther; 2022 Feb; 11(1):367-387. PubMed ID: 34877641 [TBL] [Abstract][Full Text] [Related]
39. Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations. Huang L; Goren A; Lee LK; Li VW; Dempsey A; Srivastava A Hum Vaccin Immunother; 2020 Apr; 16(4):933-944. PubMed ID: 31634035 [TBL] [Abstract][Full Text] [Related]